Evidence mapPaperPMID 41750672Full record

ReviewDiagnostics (Basel, Switzerland)2026

The Transformative Potential of Liquid Biopsies and Circulating Tumor DNA (ctDNA) in Modern Oncology.

Keren Rouvinov, Rashad Naamneh, Alexander Yakobson, Wenad Najjar, Mahmoud Abu Amna, Arina Soklakova, Ez El Din Abu Zeid, Ronen Brenner, Mohnnad Asla, Fahmi Abu Ghalion and 3 more

Abstract readReview
In one paragraph

Review in Diagnostics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Keren RouvinovThe Legacy Heritage Cancer Center, Dr. Larry Norton Institute, Soroka Medical Center, Beer-Sheva 84105, Israel.ORCID 0000-0002-8273-4723
Rashad NaamnehGoldman Medical School, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel.ORCID 0009-0004-0461-9633
Alexander YakobsonThe Legacy Heritage Cancer Center, Dr. Larry Norton Institute, Soroka Medical Center, Beer-Sheva 84105, Israel.
Wenad NajjarNeurosurgery Department, Hadassah Hebrew University Medical Center, Jerusalem 91200, Israel.ORCID 0009-0003-8370-0992
Mahmoud Abu AmnaDepartment of Oncology, The Emek Medical Centre, Afula 18341, Israel.ORCID 0000-0003-0571-9287
Arina SoklakovaMedical School for International Health, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva 84105, Israel.
Ez El Din Abu ZeidGoldman Medical School, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel.
Ronen BrennerEdith Wolfson Medical Center, Oncology Institute, Holon 58220, Israel.
Mohnnad AslaGoldman Medical School, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel.
Fahmi Abu GhalionGoldman Medical School, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel.ORCID 0009-0002-6840-790X
Ali Abu Juma'aGoldman Medical School, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel.
Amichay MeirovitzThe Legacy Heritage Cancer Center, Dr. Larry Norton Institute, Soroka Medical Center, Beer-Sheva 84105, Israel.
Walid ShalataThe Legacy Heritage Cancer Center, Dr. Larry Norton Institute, Soroka Medical Center, Beer-Sheva 84105, Israel.ORCID 0000-0002-7570-4550

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cancercirculating tumor DNA (ctDNA)liquid biopsyminimal residual disease (MRD)precision oncology

Identifiers

PMID41750672
PMCPMC12938931

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.